Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. | Director | Common Stock | 25.1K | $1.13M | $45.00 | Jun 18, 2024 | Direct |
MCKESSON CORP | Director | Restricted Stock Units (RSUs) | 349 | $203K | $580.92 | Jul 31, 2024 | Direct |
Syros Pharmaceuticals, Inc. | Director | Common Stock | 12K | $59.4K | $4.95 | Jun 1, 2024 | Direct |
Syros Pharmaceuticals, Inc. | Director | Restricted Stock Units | 4K | $19.8K | $4.95 | Jun 5, 2024 | Direct |
Ultragenyx Pharmaceutical Inc. | Director | Stock Option (Right to Buy) | 9.9K | Jun 18, 2024 | Direct | ||
Syros Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 6K | Jun 5, 2024 | Direct | ||
ALEXION PHARMACEUTICALS, INC. | Director | Common Stock, par value $.0001 per share | 0 | $177.00 | Jul 21, 2021 | Direct |